Vicki Sato Reports Vir Biotechnology Security Changes
Ticker: VIR · Form: 4 · Filed: 2026-04-02T10:46:41-04:00
Sentiment: neutral
Topics: insider-transaction, form-4, ownership-change
Related Tickers: VIR
TL;DR
Vicki Sato updated her Vir Bio holdings on 4/1/26.
AI Summary
On April 1, 2026, Vicki L. Sato reported a change in beneficial ownership of securities for Vir Biotechnology, Inc. The filing, dated April 2, 2026, details transactions related to her holdings in the company.
Why It Matters
This filing provides insight into the trading activity and beneficial ownership changes of a key executive at Vir Biotechnology, Inc.
Risk Assessment
Risk Level: low — Form 4 filings typically report routine changes in beneficial ownership by insiders and do not inherently signal significant risk.
Key Numbers
- 2026-04-01 — Period of Report (Date of reported transactions)
- 2026-04-02 — Filing Date (Date the report was officially submitted)
Key Players & Entities
- Vicki L. Sato (person) — Reporting Person
- Vir Biotechnology, Inc. (company) — Issuer
- 0001706431 (company) — Vir Biotechnology CIK
- 0001197020 (person) — Vicki L. Sato CIK
FAQ
What specific transactions were reported by Vicki L. Sato?
The filing is a Form 4, which reports changes in beneficial ownership. Specific transaction details (buys, sells, grants, etc.) would be found within the document's tables, which are not fully detailed in the provided text.
What is Vicki L. Sato's role at Vir Biotechnology, Inc.?
Vicki L. Sato is listed as the Reporting Person for Vir Biotechnology, Inc., indicating she is an insider with reporting obligations.
When was this Form 4 filing accepted by the SEC?
The filing was accepted on April 2, 2026, at 10:46:41.
What is the CIK number for Vir Biotechnology, Inc.?
The CIK number for Vir Biotechnology, Inc. is 0001706431.
What is the business address for Vir Biotechnology, Inc.?
The business address for Vir Biotechnology, Inc. is 1800 OWENS STREET SUITE 900 SAN FRANCISCO CA 94158.
From the Filing
EDGAR Filing Documents for 0001628280-26-022971 This page uses Javascript. Your browser either doesn't support Javascript or you have it turned off. To see this page as it is meant to appear please use a Javascript enabled browser. SEC.gov EDGAR Latest Filings Filings search tools Filing Detail SEC Home » Company Search » Current Page Form 4 - Statement of changes in beneficial ownership of securities: SEC Accession No. 0001628280-26-022971 Filing Date 2026-04-02 Accepted 2026-04-02 10:46:41 Documents 1 Period of Report 2026-04-01 Document Format Files Seq Description Document Type Size 1 FORM 4 wk-form4_1775141198.html 4 1 FORM 4 wk-form4_1775141198.xml 4 3887 Complete submission text file 0001628280-26-022971.txt 5379 Mailing Address 940 WINTER STREET PERKINELMER, INC. LEGAL DEPARTMENT WALTHAM MA 02451 Business Address SATO VICKI L ( Reporting ) CIK : 0001197020 (see all company filings) Type: 4 | Act: 34 | File No.: 001-39083 | Film No.: 26831269 Mailing Address 1800 OWENS STREET SUITE 900 SAN FRANCISCO CA 94158 Business Address 1800 OWENS STREET SUITE 900 SAN FRANCISCO CA 94158 415-906-4324 Vir Biotechnology, Inc. ( Issuer ) CIK : 0001706431 (see all company filings) EIN. : 812730369 | State of Incorp.: DE | Fiscal Year End: 1231 SIC : 2836 Biological Products, (No Diagnostic Substances) (CF Office: 03 Life Sciences)